12-48526314-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001390849.1(OR8S1):c.683T>G(p.Ile228Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,834 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001390849.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR8S1 | NM_001390849.1 | c.683T>G | p.Ile228Ser | missense_variant | Exon 1 of 1 | ENST00000641651.1 | NP_001377778.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR8S1 | ENST00000641651.1 | c.683T>G | p.Ile228Ser | missense_variant | Exon 1 of 1 | NM_001390849.1 | ENSP00000493379.1 | |||
ENSG00000197376 | ENST00000551654.1 | n.184-1558T>G | intron_variant | Intron 1 of 1 | 6 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461834Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727224
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.683T>G (p.I228S) alteration is located in exon 1 (coding exon 1) of the OR8S1 gene. This alteration results from a T to G substitution at nucleotide position 683, causing the isoleucine (I) at amino acid position 228 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.